Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.125
Bid: 10.75
Ask: 11.50
Change: 1.125 (11.25%)
Spread: 0.75 (6.977%)
Open: 10.00
High: 11.125
Low: 9.875
Prev. Close: 10.00
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price

Tue, 28th Apr 2020 14:43

(Alliance News) - The follow is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News:

----------

easyHotel PLC - Citrus Holdco Ltd, the investment vehicle of Chair Hermanus Meijer, Non-Executive Director Charles Persello, and Michael Neuman, representative of corporate director Cadim Fonds Inc, buys 183,688 shares at GBP0.70, worth GBP128,582, on Friday last week. At the start of last week, easyHotel offered an exit opportunity to minority shareholders at the same price. Citrus Holdco held 71.2% of the shares at that point, with brand-owner easyGroup having 25.8%, leaving just 3% in public hands. easyHotel plans to cancel its listing on AIM from May 19.

----------

Witan Investment Trust PLC - Non-Executive Director Gabrielle Boyle buys 28,683 shares at 173.41p, worth GBP49,739, on Monday.

----------

Scancell Holdings PLC - Non-Executive Director Martin Diggle sells 2.0 million shares via Vulpes Life Science Fund, at 8p, worth GBP160,000, on Monday and Friday last week. Vulpes now holds 78.5 million shares, a 17% stake.

----------

Manchester & London Investment Trust PLC - Investment Manager Mark Sheppard sells 58,266 shares at GBP5.62 and GBP5.66, worth GBP327,586, on Monday.

----------

Geiger Counter Ltd - Chair George Baird buys 100,000 shares at GBP0.17, worth GBP16,680, on Friday last week.

----------

Alfa Financial Software Holdings PLC - Chief Financial Officer Duncan Magrath buys 100,000 shares at GBP0.79, worth GBP79,000, on Monday.

----------

Artemis Alpha Trust PLC - Fund Manager Kartik Kumar buys 12,500 shares at GBP2.45, worth GBP30,625, on Friday last week.

----------

Jadestone Energy Inc - Non-Executive Chair Dennis McShane buys 150,732 shares at 43.02p to 44.40p, worth GBP65,337, on Friday last week and Monday. Now holds 453,651 shares.

----------

Salt Lake Potash Ltd - Chair Ian Middlemas buys 2.3 million shares, CEO Tony Swiericzuk 505,883, and CFO Shaun Day 102,941 last week, as part of company's placement of 58.8 million shares at AUD0.34 to raise AUD20.0 million. The funds will be used to deliver the Lake Way project in Western Australia. Salt Lake Potash said commissioning is expected to commence in December with first production in the first quarter of 2021.

----------

City Merchants High Yield Trust Ltd - Non-executive directors Tim Scholefield and Stuart McMaster buy 6,000 shares at 171.80p and 25,000 shares at 171.67p, respectively, on Tuesday. The purchases are together worth GBP53,000.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
13 Oct 2014 14:57

UK AGM, EGM Calendar - Week Ahead

Read more
13 Oct 2014 05:30

UK AGM, EGM Calendar - Week Ahead

Read more
10 Oct 2014 14:48

UK AGM, EGM Calendar - Week Ahead

Read more
10 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

Read more
9 Oct 2014 15:15

UK AGM, EGM Calendar - Week Ahead

Read more
9 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

Read more
8 Oct 2014 14:58

UK AGM, EGM Calendar - Week Ahead

Read more
8 Oct 2014 05:26

UK AGM, EGM Calendar - Week Ahead

Read more
7 Oct 2014 15:05

UK AGM, EGM Calendar - Week Ahead

Read more
4 Sep 2014 11:23

Scancell Holdings sees annual losses widen

Scancell Holdings, a developer of novel immunotherapies for the treatment of cancer, made an annual loss of £2.22m in the year to 30 April compared to £1.9m last year. The company development spending increased due to additional costs in pre-clinical studies for a new platform technology, while adm

Read more
4 Sep 2014 09:36

Scancell Full-Year Loss Widens On Development, Administrative Costs

Read more
12 Aug 2014 11:14

UK MIDDAY BRIEFING: Serco CEO Bolsters Top Team Again

Read more
12 Aug 2014 11:03

UK WINNERS & LOSERS: Just Eat Delivers Tasty Revenue Growth

Read more
12 Aug 2014 08:12

Scancell Boosted By Positive Results SCIB1, PD-1 Combination

Read more
12 Aug 2014 07:35

UK MORNING BRIEFING: Just Eat Leads Mixed Market On Mobile Sales

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.